| Disease | rheumatoid arthritis |
| Comorbidity | C0042721|viral hepatitis |
| Sentences | 1 |
| PubMedID- 25549599 | Coexistence of severe rheumatoid disease with chronic viral hepatitis (hepatitis) type b makes the treatment of abatacept, tocilizumab or rituximab risky because it can lead to reactivation of viral infection. |
Page: 1